{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:43:05Z","timestamp":1790800985901,"version":"4.1.0"},"reference-count":76,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T00:00:00Z","timestamp":1576108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0226347","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T18:41:38Z","timestamp":1576176098000},"page":"e0226347","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Inflammatory mediators and lung abnormalities in HIV: A systematic review"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6613-017X","authenticated-orcid":true,"given":"Breanne M.","family":"Head","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruochen","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Keynan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulma Vanessa","family":"Rueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"issue":"1","key":"pone.0226347.ref001","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/QCO.0b013e32835ba6b1","article-title":"Life expectancy living with HIV: Recent estimates and future implications","volume":"26","author":"F Nakagawa","year":"2013","journal-title":"Curr Opin Infect Dis"},{"issue":"6","key":"pone.0226347.ref002","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1183\/09031936.00155813","article-title":"Community-acquired lung respiratory infections in HIV-infected patients: Microbial aetiology and outcome","volume":"43","author":"C Cilloniz","year":"2014","journal-title":"Eur Respir J"},{"issue":"12","key":"pone.0226347.ref003","first-page":"1","article-title":"Atypical bacterial pneumonia in the HIV-infected population","volume":"9","author":"BM Head","year":"2017","journal-title":"Pneumonia"},{"issue":"3","key":"pone.0226347.ref004","doi-asserted-by":"crossref","first-page":"e0149679","DOI":"10.1371\/journal.pone.0149679","article-title":"HIV Impairs Lung Epithelial Integrity and Enters the Epithelium to Promote Chronic Lung Inflammation","volume":"11","author":"KA Brune","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"pone.0226347.ref005","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0272-5231(05)70337-3","article-title":"Immunologic effects of HIV in the lung","volume":"17","author":"C Agostini","year":"1996","journal-title":"Clin Chest Med"},{"issue":"4","key":"pone.0226347.ref006","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1475-097X.2012.01124.x","article-title":"Changes in lung function of HIV-infected patients: A 4\u00b75-year follow-up study","volume":"32","author":"US Kristoffersen","year":"2012","journal-title":"Clin Physiol Funct Imaging"},{"key":"pone.0226347.ref007","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/HIV.S6882","article-title":"HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites","volume":"2","author":"NK Saksena","year":"2010","journal-title":"HIV\/AIDS\u2014Res Palliat Care"},{"key":"pone.0226347.ref008","unstructured":"Mascolini M. Faster lung function decline with HIV linked to sCD14 activation marker. Conf Reports NATAP [Internet]. 2014; https:\/\/www.thieme-connect.com\/DOI\/DOI?10.1055\/s-2004-822307"},{"key":"pone.0226347.ref009","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1513\/pats.201009-059WR","article-title":"HIV-associated lung infections and complications in the era of combination antiretroviral therapy","volume":"8","author":"K Crothers","year":"2011","journal-title":"Proc Am Thorac Soc"},{"issue":"February","key":"pone.0226347.ref010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-y: an overview of signals, mechanisms and functions","volume":"75","author":"K Schroder","year":"2004","journal-title":"J Leukoc Biol"},{"issue":"5","key":"pone.0226347.ref011","first-page":"1","article-title":"HIV infection is associated with elevated biomarkers of immune activation in Ugandan adults with pneumonia","volume":"14","author":"RJ Wang","year":"2019","journal-title":"PLoS One"},{"key":"pone.0226347.ref012","first-page":"1","article-title":"Airflow limitation in people living with HIV and matched uninfected controls","volume":"0","author":"A Ronit","year":"2018","journal-title":"Thorax"},{"issue":"2","key":"pone.0226347.ref013","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1513\/AnnalsATS.201606-492OC","article-title":"Decreased lung function and all-cause mortality in HIV-infected individuals","volume":"15","author":"MR Gingo","year":"2018","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"pone.0226347.ref014","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/QAD.0b013e32835e395d","article-title":"The effect of HIV infection on longitudinal lung function decline among injection drug users: A prospective cohort","volume":"27","author":"MB Drummond","year":"2013","journal-title":"AIDS"},{"key":"pone.0226347.ref015","first-page":"397","article-title":"Association of HIV infection and immune activation with decline in lung function","volume":"22","author":"K Crothers","year":"2014","journal-title":"Top Antivir Med"},{"issue":"2","key":"pone.0226347.ref016","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.acra.2016.09.019","article-title":"HIV infection is independently associated with increased CT scan lung density","volume":"24","author":"MB Drummond","year":"2017","journal-title":"Acad Radiol"},{"issue":"10","key":"pone.0226347.ref017","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1093\/infdis\/jiw422","article-title":"HIV suppression restores the lung mucosal CD4+T-cell viral immune response and resolves CD8+T-cell alveolitis in patients at risk for HIV-associated chronic obstructive pulmonary disease","volume":"214","author":"I Popescu","year":"2016","journal-title":"J Infect Dis"},{"key":"pone.0226347.ref018","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1016\/S2214-109X(17)30451-5","article-title":"Prevalence of chronic obstructive pulmonary disease in the global population with HIV: A systematic review and meta-analysis","volume":"6","author":"JJ Bigna","year":"2018","journal-title":"Lancet Glob Heal"},{"issue":"7","key":"pone.0226347.ref019","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S2213-2600(14)70017-7","article-title":"HIV-associated obstructive lung diseases: Insights and implications for the clinician","volume":"2","author":"MB Drummond","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"3","key":"pone.0226347.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11908-016-0516-y","article-title":"Relevant Cytokines in the Management of Community-Acquired Pneumonia","volume":"18","author":"A Rendon","year":"2016","journal-title":"Curr Infect Dis Rep"},{"issue":"4","key":"pone.0226347.ref021","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s10753-014-9840-2","article-title":"Contrasting inflammatory responses in severe and non-severe community-acquired pneumonia","volume":"37","author":"R Fernandez-Botran","year":"2014","journal-title":"Inflammation"},{"issue":"147","key":"pone.0226347.ref022","doi-asserted-by":"crossref","first-page":"170077","DOI":"10.1183\/16000617.0077-2017","article-title":"Tuberculosis and lung damage: from epidemiology to pathophysiology","volume":"27","author":"S Ravimohan","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"11","key":"pone.0226347.ref023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0080302","article-title":"High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: Under-recognised phenomena","volume":"8","author":"AP Ralph","year":"2013","journal-title":"PLoS One"},{"issue":"August 2012","key":"pone.0226347.ref024","first-page":"67","volume":"17","author":"CK Rhee","year":"2013","journal-title":"Clinical characteristics of patients with tuberculosis-destroyed lung"},{"key":"pone.0226347.ref025","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2466-10-44","article-title":"Persistent Chlamydia Pneumoniae serology is related to decline in lung function in women but not in men. Effect of persistent Chlamydia pneumoniae infection on lung function","volume":"10","author":"T Gislason","year":"2010","journal-title":"BMC Pulm Med"},{"issue":"7","key":"pone.0226347.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0006328","article-title":"Respiratory symptoms and airway obstruction in HIV-infected subjects in the HAART era","volume":"4","author":"MP George","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"pone.0226347.ref027","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/00365549509032730","article-title":"Persistent reduction in lung function after Pneumocystis carinii pneumonia in AIDS patients","volume":"27","author":"S Nelsing","year":"1995","journal-title":"Scand J Infect Dis"},{"key":"pone.0226347.ref028","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1164\/ajrccm.162.2.9912058","article-title":"Permanent declines in pulmonary function following pneumonia in Human Immunodeficiency Virus-infected persons","volume":"162","author":"AM Morris","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0226347.ref029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/CMR.00034-13","article-title":"Gamma interferon release assays for detection of Mycobacterium tuberculosis infection","volume":"27","author":"M Pai","year":"2014","journal-title":"Clin Microbiol Rev"},{"issue":"7","key":"pone.0226347.ref030","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"Jan02 1","key":"pone.0226347.ref031","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis (PRISMA) protocols 2015 checklist","volume":"349","author":"L Shamseer","year":"2015","journal-title":"Br Med J"},{"key":"pone.0226347.ref032","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/9780470988343.app1","article-title":"Jadad scale for reporting randomized controlled trials","author":"SH Halpern","year":"2005","journal-title":"Evidence-based Obstet Anesth"},{"key":"pone.0226347.ref033","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J. Newcastle-Ottawa Quality Assessment Scale. In: Coding Manual for Cohort Studies [Internet]. p. 1\u20132. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/nosgen.pdf"},{"key":"pone.0226347.ref034","unstructured":"National Institute of Health. Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies\u2014NHLBI, NIH [Internet]. 2014. p. 1\u20134. https:\/\/www.nhlbi.nih.gov\/health-pro\/guidelines\/in-develop\/cardiovascular-risk-reduction\/tools\/cohort"},{"issue":"6","key":"pone.0226347.ref035","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1378\/chest.14-0543","article-title":"Increased Risk of Radiographic Emphysema in HIV Is Associated With Elevated Soluble CD14 and Nadir CD4","volume":"146","author":"EF Attia","year":"2014","journal-title":"Chest"},{"issue":"4","key":"pone.0226347.ref036","doi-asserted-by":"crossref","first-page":"e95099","DOI":"10.1371\/journal.pone.0095099","article-title":"A cross sectional analysis of the role of the antimicrobial peptide cathelicidin in lung function impairment within the ALIVE cohort","volume":"9","author":"AA Lambert","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"pone.0226347.ref037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0170857","article-title":"A low peripheral blood CD4\/CD8 ratio is associated with pulmonary emphysema in HIV","volume":"12","author":"M Triplette","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"pone.0226347.ref038","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/QAD.0000000000001092","article-title":"Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons","volume":"30","author":"ME Fitzpatrick","year":"2016","journal-title":"Aids"},{"issue":"17","key":"pone.0226347.ref039","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1097\/QAD.0000000000000471","article-title":"Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort","volume":"28","author":"ME Fitzpatrick","year":"2014","journal-title":"AIDS"},{"issue":"5","key":"pone.0226347.ref040","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/QAI.0000000000001711","article-title":"Systemic inflammation, immune activation, and impaired lung function among people living with HIV in rural Uganda","volume":"78","author":"CM North","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"pone.0226347.ref041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14814\/phy2.12756","article-title":"Widespread activation of immunity and pro-inflammatory programs in peripheral blood leukocytes of HIV-infected patients with impaired lung gas exchange","volume":"4","author":"K Crothers","year":"2016","journal-title":"Physiol Rep"},{"key":"pone.0226347.ref042","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.2147\/COPD.S141068","article-title":"Differences in systemic inflammation between cigarette and biomass smoke-induced COPD","volume":"12","author":"R Golpe","year":"2017","journal-title":"Int J COPD"},{"issue":"5","key":"pone.0226347.ref043","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1378\/chest.130.5.1326","article-title":"Increased COPD among HIV-positive compared to HIV-negative veterans","volume":"130","author":"K Crothers","year":"2006","journal-title":"Chest"},{"issue":"1","key":"pone.0226347.ref044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-5876-12-9","article-title":"Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study","volume":"12","author":"WK O\u2019Neal","year":"2014","journal-title":"J Transl Med"},{"issue":"2","key":"pone.0226347.ref045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5507\/bp.2017.029","article-title":"Inflammatory, anti-inflammatory and regulatory cytokines in relatively healthy lung tissue as an essential part of the local immune system","volume":"161","author":"Z Vitenberga","year":"2017","journal-title":"Biomed Pap"},{"issue":"2","key":"pone.0226347.ref046","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ppul.10139","article-title":"Cytokine secretion in children with acute Mycoplasma pneumoniae infection and wheeze","volume":"34","author":"S Esposito","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"125","key":"pone.0226347.ref047","first-page":"1","article-title":"Role of TNF \u03b1 in pulmonary pathophysiology","volume":"7","author":"S Mukhopadhyay","year":"2006","journal-title":"Respir Res"},{"issue":"4","key":"pone.0226347.ref048","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1183\/09031936.02.00295102","article-title":"Systemic cytokine levels in community-acquired pneumonia and their association with disease severity","volume":"20","author":"G Antunes","year":"2002","journal-title":"Eur Respir J"},{"issue":"6","key":"pone.0226347.ref049","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1183\/09031936.00060112","article-title":"Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia","volume":"41","author":"MS Paats","year":"2013","journal-title":"Eur Respir J"},{"issue":"2","key":"pone.0226347.ref050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/ars.2007.1903","article-title":"Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis","volume":"10","author":"R-M Liu","year":"2008","journal-title":"Antioxidants Redox Signal"},{"issue":"2","key":"pone.0226347.ref051","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4049\/jimmunol.158.2.954","article-title":"TNF-a-Medicated Lung Cytokine Networking and Eosinophil Recruitment in Pulmonary Fibrosis","volume":"158","author":"K Zhang","year":"1997","journal-title":"J Immunol"},{"issue":"October","key":"pone.0226347.ref052","first-page":"1","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"GA Duque","year":"2014","journal-title":"Front Immunol"},{"key":"pone.0226347.ref053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1465-9921-11-32","article-title":"Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases","volume":"11","author":"V Marcos","year":"2010","journal-title":"Respir Res"},{"issue":"2","key":"pone.0226347.ref054","doi-asserted-by":"crossref","first-page":"e89341","DOI":"10.1371\/journal.pone.0089341","article-title":"Plasma sCD14 as a biomarker to predict pulmonary exacerbations in cystic fibrosis","volume":"9","author":"BS Quon","year":"2014","journal-title":"PLoS One"},{"issue":"209","key":"pone.0226347.ref055","first-page":"1","article-title":"Poll T Van Der, Vos AF De. Role of CD14 in lung inflammation and infection","volume":"14","author":"A Anas","year":"2010","journal-title":"Crit Care"},{"issue":"6","key":"pone.0226347.ref056","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1164\/rccm.200606-824OC","article-title":"CD14 facilitates invasive respiratory tract infection by Streptococcus pneumoniae","volume":"175","author":"MC Dessing","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"pone.0226347.ref057","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/infdis\/jiq118","article-title":"Plasma levels of soluble CD14 independently predict mortality in HIV infection","volume":"203","author":"NG Sandler","year":"2011","journal-title":"J Infect Dis"},{"issue":"6","key":"pone.0226347.ref058","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0158169","article-title":"Plasma CXCL10, sCD163 and sCD14 levels have distinct associations with antiretroviral treatment and cardiovascular disease risk factors","volume":"11","author":"A Castley","year":"2016","journal-title":"PLoS One"},{"key":"pone.0226347.ref059","article-title":"Higher ART adherence is associated with lower systemic inflammation in treatment-na\u00efve Ugandans who achieve virologic suppression","volume":"1","author":"JR CASTILLO-MANCILLA","year":"2018","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"10","key":"pone.0226347.ref060","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1097\/01.CCM.0000239120.32490.AB","article-title":"Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163","volume":"34","author":"HJ M\u00f8ller","year":"2006","journal-title":"Crit Care Med"},{"issue":"2","key":"pone.0226347.ref061","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2478\/acb-2014-0005","article-title":"Cathelicidin\u2013Its Structure, Function and the Role in Autoimmune Diseases","volume":"4","author":"M Polcyn-Adamczak","year":"2014","journal-title":"Adv Cell Biol"},{"key":"pone.0226347.ref062","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-319-24199-9_3","volume-title":"Antimicrobial Peptides: Role in Human Health and Disease","author":"F Seiler","year":"2016"},{"issue":"3","key":"pone.0226347.ref063","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1128\/IAI.01218-07","article-title":"Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells","volume":"76","author":"B Rivas-Santiago","year":"2008","journal-title":"Infect Immun"},{"issue":"16","key":"pone.0226347.ref064","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1073\/pnas.95.16.9541","article-title":"The peptide antibiotic LL-37\/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface","volume":"95","author":"R Bals","year":"1998","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"pone.0226347.ref065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1159\/000335901","article-title":"Signaling pathways mediating chemokine induction in keratinocytes by cathelicidin LL-37 and flagellin","volume":"4","author":"A Nijnik","year":"2012","journal-title":"J Innate Immun"},{"issue":"6","key":"pone.0226347.ref066","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1378\/chest.108.6.1614","article-title":"Increased soluble CD14 levels in BAL fluid in pulmonary tuberculosis","volume":"108","author":"G Hoheisel","year":"1995","journal-title":"Chest"},{"issue":"1","key":"pone.0226347.ref067","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11904-012-0140-x","article-title":"Pathogenesis of HIV and the lung","volume":"10","author":"MR Gingo","year":"2013","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"17","key":"pone.0226347.ref068","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1097\/QAD.0000000000000471","article-title":"Relationships of pulmonary function, inflammation, and T-cell activation and senescence in an HIV-infected cohort","volume":"28","author":"M Fitzpatrick","year":"2014","journal-title":"AIDS"},{"issue":"9","key":"pone.0226347.ref069","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/QAD.0000000000001092","article-title":"Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons","volume":"30","author":"ME Fitzpatrick","year":"2016","journal-title":"AIDS"},{"issue":"4","key":"pone.0226347.ref070","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/QAI.0000000000001840","article-title":"Factors Associated With Progression of Lung Function Abnormalities in HIV- Infected Individuals","volume":"79","author":"Y Li","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"pone.0226347.ref071","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0184530","article-title":"Factors associated with pulmonary impairment in HIV-infected South African adults","volume":"12","author":"AN Gupte","year":"2017","journal-title":"PLoS One"},{"issue":"December","key":"pone.0226347.ref072","first-page":"980","article-title":"Pulmonary eff ects of immediate versus deferred antiretroviral therapy in HIV-positive individuals: a nested substudy within the multicentre, international, randomised, controlled Strategic Timing of Antiretroviral Treatment (START) trial","volume":"4","author":"KM Kunisaki","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"pone.0226347.ref073","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1172\/JCI121935","article-title":"Cigarette smoke and HIV synergistically affect lung pathology in cynomolgus macaques","volume":"128","author":"HS Chand","year":"2018","journal-title":"J Clin Invest"},{"issue":"3","key":"pone.0226347.ref074","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1183\/09031936.00052709","article-title":"The impact of time on the systemic inflammatory response in pneumococcal pneumonia","volume":"35","author":"E Calbo","year":"2010","journal-title":"Eur Respir J"},{"issue":"5","key":"pone.0226347.ref075","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1128\/CDLI.10.5.813-820.2003","article-title":"Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia","volume":"10","author":"S Fern\u00e1ndez-Serrano","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"7","key":"pone.0226347.ref076","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.00658-07","article-title":"Systemic expression of cytokine production in patients with severe pneumococcal pneumonia: Effects of treatment with a \u03b2-lactam versus a fluoroquinolone","volume":"52","author":"E Calbo","year":"2008","journal-title":"Antimicrob Agents Chemother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0226347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T22:57:21Z","timestamp":1695509841000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0226347"}},"subtitle":[],"editor":[{"given":"Eliseo A.","family":"Eugenin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":76,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,12,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0226347","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]}}}